24.42MMarket Cap-142P/E (TTM)
3.7000High3.3590Low8.38KVolume3.3590Open3.1500Pre Close29.70KTurnover0.24%Turnover RatioLossP/E (Static)6.80MShares9.200052wk High15.28P/B12.33MFloat Cap2.950052wk Low--Dividend TTM3.44MShs Float583.5000Historical High--Div YieldTTM10.83%Amplitude2.9500Historical Low3.5430Avg Price1Lot Size
PolyPid Stock Forum
Unblinded Interim Analysis to be Conducted Once Approximately 400 PatientsComplete Their 30-Day Follow-up; Top-line Results Expected in the First Quarter of 2025
NEWS
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
Yo @Mcsnacks H Tupack I had this one on my watchlist but don't remember why. Was this one of your calls?
No comment yet